The Patent Finder

Pandion Therapeutics, Inc.

Also on record
Records under this name other than the patents Pandion Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 10 of 10 · Back to Pandion Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,676,516Targeted immunotolerance
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,961,310Targeted immunotolerance
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,466,068Targeted immunotolerance
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,174,091IL-2 muteins
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,174,092IL-2 Muteins
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,091,527IL-2 Muteins and Uses Thereof
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,945,852IL-2 muteins and uses thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,779,632IL-2 muteins and uses thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,739,146MAdCAM targeted immunotolerance
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,946,068IL-2 muteins and uses thereof
Formerly held
Surrendered on reissue
Surrendered on reissue Aug 26, 2025 · USPTO record
Surrendered on reissueSurrendered on reissue Aug 26, 2025USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited